Moving gene therapy forward with mobile DNA

Human Gene Therapy

Volumn 20, Issue 12, 2009, Pages 1559-1561

  Vandendriessche, Thierry ^a   Chuah, Marinee K L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LENTIVIRUS VECTOR; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARCINOGENESIS; CELL DIVISION; DNA MODIFICATION; GENE THERAPY; GENETIC ENGINEERING; GENOME; HEMATOPOIETIC CELL; HUMAN; NONHUMAN; NOTE; PROGENY; PROTEIN EXPRESSION; RETROVIRUS; STEM CELL; TRANSPOSON;

DNA TRANSPOSABLE ELEMENTS; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LENTIVIRUS; RECOMBINATION, GENETIC;

EID: 74549168955     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.1109     Document Type: Note

References (19)

1. Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Sla-vin, S., Al-Mousa, H., Al Ghonaium, A., Ferster, A., Dup-penthaler, A., Notarangelo, L., Wintergerst, U., Buckley, R.H., Bregni, M., Marktel, S., Valsecchi, M.G., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C., and Roncarolo, M.G. (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 360, 447-458.
2. Baus, J., Liu, L., Heggestad, A.D., Sanz, S., and Fletcher, B.S. (2005). Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol. Ther. 12, 1148-1156.
3. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, M., Dal-Cortivo, L., Caccavelli, L., Mahlaoui, N., Kiermer, V., Mittelstaedt, D., Bellesme, C., Lahlou, N., Lefre're, F., Blanche, S., Audit, M., Payen, E., Leboulch, P., l'Homme, B., Bougne'res, P., Von Kalle, C., Fischer, A., Cavazzana-Calvo, M., and Aubourg, P. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818-823.
4. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Deist, F.L., and Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672. (Pubitemid 30241569)
5. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., MacIntyre, E., Dal Cortivo, L., Rad-ford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Bor-khardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A., and Cavazzana-Calvo, M. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 18, 3132-3142.
6. + hematopoietic cells using the Sleeping Beauty transposon. Exp. Hematol. 34, 1333-1343.
7. Ivics, Z., Hackett, P.B., Plasterk, R.H., and Izsvak, Z. (1997). Molecular reconstruction of Sleeping Beauty, a Tc1-like trans-poson from fish, and its transposition in human cells. Cell 91, 501-510.
8. Kohn, D.B., and Candotti, F. (2009). Gene therapy fulfilling its promise. N. Engl. J. Med. 360, 518-521.
9. Lombardo, A., Genovese, P., Beausejour, C.M., Colleoni, S., Lee, Y.L., Kim, K.A., Ando, D., Urnov, F.D., Galli, C., Gregory, P.D., Holmes, M.C., and Naldini, L. (2007). Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306.
10. Mátés, L., Chuah, M.K., Belay, E., Jerchow, B., Manoj, N., Acosta-Sanchez, A., Grzela, D.P., Schmitt, A., Becker, K., Matrai, J., Ma, L., Samara-Kuko, E., Gysemans, C., Pry-putniewicz, D., Miskey, C., Fletcher, B., VandenDriessche, T., Ivics, Z., and Izsvák, Z. (2009). Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 41, 753-761.
11. Modlich, U., and Baum, C. (2009). Preventing and exploiting the oncogenic potential of integrating gene vectors. J. Clin. Invest. 119, 755-758.
12. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C.C., Ranzani, M., Benedicenti, F., Sergi, L.S., Ambrosi, A., Ponzoni, M., Doglioni, C., Di Serio, C., von Kalle, C., and Naldini, L. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 119, 964-975.
13. Naldini, L. (2009). A comeback for gene therapy. Science 326, 805-806.
14. Singh, H., Manuri, P.R., Olivares, S., Dara, N., Dawson, M.J., Huls, H., Hackett, P.B., Kohn, D.B., Shpall, E.J., Champlin, R.E., and Cooper, L.J. (2008). Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system. Cancer Res. 68, 2961-2971.
15. + hematopoietic stem=progenitor cells using the Sleeping Beauty transposon system. Hum. Gene Ther. 20, 1607-1626.
16. VandenDriessche, T. (2009). Gene therapy delivers. Hum. Gene Ther. 20, 1222-1223.
17. VandenDriessche, T., Ivics, Z., Izsvák, Z., and Chuah, M.K. (2009). Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood 114, 1461-1468.
18. Walisko, O., Schorn, A., Rolfs, F., Devaraj, A., Miskey, C., Izs-vák, Z., and Ivics, Z. (2008). Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol. Ther. 16, 359-369.
19. + hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 114, 1319-1330.